drugset / Trial / NCT06795204
Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
RandomizedCrossoverQuadruple-blindTreatment
Summary
To assess the effects of a single IV bolus of HSK3486 single dose on cardiac repolarization (QTc interval of the electrocardiogram, and to evaluate the safety and tolerability of a single IV bolus of HSK3486 in healthy subjects
Timeline
- Start
- 2024-04-09
- Primary completion
- 2024-05-19
- Completion
- 2024-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipepofol | Small molecule | 0.4 mg/kg | Intravenous |
| Comparator | Moxifloxacin | Small molecule | 0.4 g | Oral |